Literature DB >> 27048899

Probiotics and prebiotics in Crohn's disease therapies.

Lev Lichtenstein1, Irit Avni-Biron2, Ofer Ben-Bassat2.   

Abstract

Therapeutic manipulation of gut microbiota has proven valuable in the management of ulcerative colitis and pouchitis. Despite some similarities among the various inflammatory bowel conditions, the probiotics investigated thus far seem to confer little benefit in Crohn's disease. In this review, we aim to bring together the evidence available on the clinical effect of probiotics and prebioltics in Crohn's disease patients, and to clarify the place of probiotic treatment in current Crohn's therapeutic regimens.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bifidobacterium; Crohn's disease; Inflammatory bowel disease; Lactobacillus; Prebiotics; Probiotics; Sacchromyces boullardi; Synbiotics; VSL#3

Mesh：

Substances：

Year:  2016        PMID： 27048899     DOI： 10.1016/j.bpg.2016.02.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN： 1521-6918            Impact factor:   3.043


  14 in total

Review 1.  Changes of intestinal microbiota and microbiota-based treatments in IBD.

Authors:  Qianyu Li; Siyu Zhou; Yanna Wang; Jing Cong
Journal:  Arch Microbiol       Date:  2022-07-01       Impact factor: 2.552

Review 2.  Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.

Authors:  Reem Rashed; Rosica Valcheva; Levinus A Dieleman
Journal:  Front Med (Lausanne)       Date:  2022-06-16

3.  Two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation.

Authors:  Daniel Röth; Abby J Chiang; Weidong Hu; Gabriel B Gugiu; Christina N Morra; James Versalovic; Markus Kalkum
Journal:  FASEB J       Date:  2018-11-19       Impact factor: 5.191

Review 4.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

Review 5.  Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis.

Authors:  Fang Yan; D Brent Polk
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

6.  Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora.

Authors:  Hui Su; Qian Kang; Haihong Wang; Hui Yin; Linghui Duan; Yuli Liu; Ruying Fan
Journal:  Exp Ther Med       Date:  2018-08-02       Impact factor: 2.447

7.  Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation.

Authors:  Benedetta Cinque; Cristina La Torre; Francesca Lombardi; Paola Palumbo; Michel Van der Rest; Maria Grazia Cifone
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

8.  Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?

Authors:  Valerio Nobili; Lorenza Putignani; Antonella Mosca; Federica Del Chierico; Pamela Vernocchi; Anna Alisi; Laura Stronati; Salvatore Cucchiara; Marco Toscano; Lorenzo Drago
Journal:  Arch Med Sci       Date:  2016-09-06       Impact factor: 3.318

9.  Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection.

Authors:  Jae Hyun Jung; In Kuk Cho; Chang Hee Lee; Gwan Gyu Song; Ji Hyun Lim
Journal:  Gut Liver       Date:  2018-03-15       Impact factor: 4.519

10.  Nutritional approach as therapeutic manipulation in inflammatory bowel disease.

Authors:  Jin Young Yoon
Journal:  Intest Res       Date:  2019-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.